Registered capital
New stem cell drug clinical trial approved
Production Platform (Independent B+A Grade Cleanroom)
Batch clinical stem cell production experience
Large-scale stem cell drug R&D and production base
ABOUT US
Jiuzhitang Maker
Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (hereinafter referred to as Jiuzhitang Maker) was established in March 2018 with a registered capital of 0.2 billion yuan. It is a biotechnology company focusing on the production, research and development and sales of stem cell drugs and regenerative medicine products. Jiuzhitang Maker has built a large-scale stem cell drug research and development and production base in Beijing Daxing Biomedical Base, China Pharmaceutical Valley, which meets the GMP standards of China, the United States and the European Union. The office production area is about 4800m ², and the production platform is equipped with four independent B- Class A clean areas, which can produce clinical-grade stem cell drugs that meet the requirements of drug declaration in China and the United States.
Business
News and Blog
Partners
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy